Literature DB >> 21411591

Nosocomial bloodstream infections in Brazilian hospitals: analysis of 2,563 cases from a prospective nationwide surveillance study.

Alexandre R Marra1, Luis Fernando Aranha Camargo, Antonio Carlos Campos Pignatari, Teresa Sukiennik, Paulo Renato Petersen Behar, Eduardo Alexandrino Servolo Medeiros, Julival Ribeiro, Evelyne Girão, Luci Correa, Carla Guerra, Carlos Brites, Carlos Alberto Pires Pereira, Irna Carneiro, Marise Reis, Marta Antunes de Souza, Regina Tranchesi, Cristina U Barata, Michael B Edmond.   

Abstract

Nosocomial bloodstream infections (nBSIs) are an important cause of morbidity and mortality. Data from a nationwide, concurrent surveillance study, Brazilian SCOPE (Surveillance and Control of Pathogens of Epidemiological Importance), were used to examine the epidemiology and microbiology of nBSIs at 16 Brazilian hospitals. In our study 2,563 patients with nBSIs were included from 12 June 2007 to 31 March 2010. Ninety-five percent of BSIs were monomicrobial. Gram-negative organisms caused 58.5% of these BSIs, Gram-positive organisms caused 35.4%, and fungi caused 6.1%. The most common pathogens (monomicrobial) were Staphylococcus aureus (14.0%), coagulase-negative staphylococci (CoNS) (12.6%), Klebsiella spp. (12.0%), and Acinetobacter spp. (11.4%). The crude mortality was 40.0%. Forty-nine percent of nBSIs occurred in the intensive-care unit (ICU). The most frequent underlying conditions were malignancy, in 622 patients (24.3%). Among the potential factors predisposing patients to BSI, central venous catheters were the most frequent (70.3%). Methicillin resistance was detected in 157 S. aureus isolates (43.7%). Of the Klebsiella sp. isolates, 54.9% were resistant to third-generation cephalosporins. Of the Acinetobacter spp. and Pseudomonas aeruginosa isolates, 55.9% and 36.8%, respectively, were resistant to imipenem. In our multicenter study, we found high crude mortality and a high proportion of nBSIs due to antibiotic-resistant organisms.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21411591      PMCID: PMC3122653          DOI: 10.1128/JCM.00376-11

Source DB:  PubMed          Journal:  J Clin Microbiol        ISSN: 0095-1137            Impact factor:   5.948


  29 in total

1.  First report of KPC-2-producing Klebsiella pneumoniae strains in Brazil.

Authors:  Jussimara Monteiro; Anderson Fernandes Santos; Marise Dutra Asensi; Gisele Peirano; Ana Cristina Gales
Journal:  Antimicrob Agents Chemother       Date:  2008-11-17       Impact factor: 5.191

2.  Effectiveness and safety of colistin: prospective comparative cohort study.

Authors:  Mical Paul; Jihad Bishara; Ariela Levcovich; Michal Chowers; Elad Goldberg; Pierre Singer; Shaul Lev; Perla Leon; Maria Raskin; Dafna Yahav; Leonard Leibovici
Journal:  J Antimicrob Chemother       Date:  2010-03-18       Impact factor: 5.790

3.  Temporal evolution of carbapenem-resistant Acinetobacter baumannii in Curitiba, southern Brazil.

Authors:  Karina Eugênia Schimith Bier; Simone Oliveira Luiz; Mara Cristina Scheffer; Ana Cristina Gales; Maria Cristina Paganini; Agnaldo José do Nascimento; Evelyn Carignano; Libera Maria Dalla Costa
Journal:  Am J Infect Control       Date:  2010-01-31       Impact factor: 2.918

4.  Nosocomial primary bloodstream infections in intensive care unit patients in a nonteaching community medical center: a 21-month prospective study.

Authors:  D K Warren; J E Zack; A M Elward; M J Cox; V J Fraser
Journal:  Clin Infect Dis       Date:  2001-09-05       Impact factor: 9.079

5.  Evolution, incidence, and susceptibility of bacterial bloodstream isolates from 519 bone marrow transplant patients.

Authors:  B A Collin; H L Leather; J R Wingard; R Ramphal
Journal:  Clin Infect Dis       Date:  2001-09-05       Impact factor: 9.079

6.  The influence of inadequate antimicrobial treatment of bloodstream infections on patient outcomes in the ICU setting.

Authors:  E H Ibrahim; G Sherman; S Ward; V J Fraser; M H Kollef
Journal:  Chest       Date:  2000-07       Impact factor: 9.410

7.  First description of bla(CTX-M-14)- and bla(CTX-M-15)-producing Escherichia coli isolates in Brazil.

Authors:  Maria Cecilia Cergole-Novella; Beatriz E C Guth; Mariana Castanheira; Mirian S Carmo; Antonio C C Pignatari
Journal:  Microb Drug Resist       Date:  2010-09       Impact factor: 3.431

8.  Multidrug-resistant Acinetobacter baumannii: an emerging pathogen among older adults in community hospitals and nursing homes.

Authors:  D M Sengstock; R Thyagarajan; J Apalara; A Mira; T Chopra; K S Kaye
Journal:  Clin Infect Dis       Date:  2010-06-15       Impact factor: 9.079

9.  International study of the prevalence and outcomes of infection in intensive care units.

Authors:  Jean-Louis Vincent; Jordi Rello; John Marshall; Eliezer Silva; Antonio Anzueto; Claude D Martin; Rui Moreno; Jeffrey Lipman; Charles Gomersall; Yasser Sakr; Konrad Reinhart
Journal:  JAMA       Date:  2009-12-02       Impact factor: 56.272

10.  Multidrug resistant Acinetobacter baumannii: a descriptive study in a city hospital.

Authors:  Lemuel L Dent; Dana R Marshall; Siddharth Pratap; Robert B Hulette
Journal:  BMC Infect Dis       Date:  2010-07-07       Impact factor: 3.090

View more
  73 in total

1.  Antibacterial and non-cytotoxic effect of nanocomposites based in polyethylene and copper nanoparticles.

Authors:  L A Tamayo; P A Zapata; F M Rabagliati; M I Azócar; L A Muñoz; X Zhou; G E Thompson; M A Páez
Journal:  J Mater Sci Mater Med       Date:  2015-02-19       Impact factor: 3.896

2.  The EMPIRICUS trial-the final nail in the coffin of empirical antifungal therapy in the intensive care unit?

Authors:  Michael Osthoff; Nina Khanna; Martin Siegemund
Journal:  J Thorac Dis       Date:  2017-03       Impact factor: 2.895

3.  Patterns and trends of pediatric bloodstream infections: a 7-year surveillance study.

Authors:  N Buetti; A Atkinson; L Kottanattu; J Bielicki; J Marschall; A Kronenberg
Journal:  Eur J Clin Microbiol Infect Dis       Date:  2016-11-24       Impact factor: 3.267

4.  Cross-resistance between voriconazole and fluconazole for non-albicans Candida infection: a case-case-control study.

Authors:  Y Wang; Q Yang; L Chen; L Liu; R Hao; T Zhang; X Wang; J Lei; J Xie; Y Dong
Journal:  Eur J Clin Microbiol Infect Dis       Date:  2017-06-15       Impact factor: 3.267

5.  Health care associated infections, antibiotic resistance and clinical outcome: A surveillance study from Sanandaj, Iran.

Authors:  Jafar Soltani; Bahman Poorabbas; Neda Miri; Jalal Mardaneh
Journal:  World J Clin Cases       Date:  2016-03-16       Impact factor: 1.337

6.  Hemolytic factor production by clinical isolates of Candida species.

Authors:  Daniel Favero; Luciana Furlaneto-Maia; Emanuele J G França; Helena Peggau Góes; Marcia Cristina Furlaneto
Journal:  Curr Microbiol       Date:  2013-09-19       Impact factor: 2.188

7.  Screening for bacteremia in sepsis and renal failure using hemofilters for renal replacement therapy.

Authors:  G P Otto; M Kropf; M Sossdorf; P Recknagel; W Lösche; J Rödel; R A Claus; M Busch
Journal:  Infection       Date:  2012-12-06       Impact factor: 3.553

8.  Early insights into the interactions of different β-lactam antibiotics and β-lactamase inhibitors against soluble forms of Acinetobacter baumannii PBP1a and Acinetobacter sp. PBP3.

Authors:  Krisztina M Papp-Wallace; Baui Senkfor; Julian Gatta; Weirui Chai; Magdalena A Taracila; Veerabahu Shanmugasundaram; Seungil Han; Richard P Zaniewski; Brian M Lacey; Andrew P Tomaras; Marion J Skalweit; Michael E Harris; Louis B Rice; John D Buynak; Robert A Bonomo
Journal:  Antimicrob Agents Chemother       Date:  2012-08-20       Impact factor: 5.191

9.  Characterisation and clinical features of Enterobacter cloacae bloodstream infections occurring at a tertiary care university hospital in Switzerland: is cefepime adequate therapy?

Authors:  Markus Hilty; Parham Sendi; Salome N Seiffert; Sara Droz; Vincent Perreten; Andrea M Hujer; Robert A Bonomo; Kathrin Mühlemann; Andrea Endimiani
Journal:  Int J Antimicrob Agents       Date:  2013-01-10       Impact factor: 5.283

10.  Intensive care unit-acquired blood stream infections: a 5-year retrospective analysis of a single tertiary care hospital in Korea.

Authors:  S J Lim; J Y Choi; S J Lee; Y J Cho; Y Y Jeong; H C Kim; J D Lee; Y S Hwang
Journal:  Infection       Date:  2014-07-17       Impact factor: 3.553

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.